Critical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cells

被引:63
作者
Kanada, Shunsuke [2 ]
Nishiyama, Chiharu [1 ]
Nakano, Nobuhiro
Suzuki, Ryuyo
Maeda, Keiko
Hara, Mutsuko
Kitamura, Nao
Ogawa, Hideoki
Okumura, Ko [2 ]
机构
[1] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan
关键词
NF-KAPPA-B; T-CELLS; GENE-EXPRESSION; ALLOGRAFT SURVIVAL; COSTIMULATORY MOLECULE; REGULATORY FACTOR-4; COUNTER-RECEPTOR; CUTTING EDGE; MAST-CELLS; ACTIVATION;
D O I
10.1182/blood-2010-06-291898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, we investigated the role of a transcription factor, PU.1, in the regulation of CD80 and CD86 expression in dendritic cells (DCs). A chromatin immunoprecipitation assay revealed that PU.1 is constitutively bound to the CD80 and CD86 promoters in bone marrow-derived DCs. In addition, co-expression of PU.1 resulted in the transactivation of the CD80 and CD86 promoters in a reporter assay. The binding of PU.1 to cis-enhancing regions was confirmed by electromobility gel-shift assay. As expected, inhibition of PU.1 expression by short interfering RNA (siRNA) in bone marrow-derived DCs resulted in marked down-regulation of CD80 and CD86 expression. Moreover, overexpression of PU.1 in murine bone marrow-derived lineage-negative cells induced the expression of CD80 and CD86 in the absence of monocyte/DC-related growth factors and/or cyto- kines. Based on these results, we conclude that PU.1 is a critical factor for the expression of CD80 and CD86. We also found that subcutaneous injection of PU.1 siRNA or topical application of a cream-emulsified PU.1 siRNA efficiently inhibited murine contact hypersensitivity. Our results suggest that PU.1 is a potential target for the treatment of immune-related diseases. (Blood. 2011;117(7):2211-2222)
引用
收藏
页码:2211 / 2222
页数:12
相关论文
共 54 条
[31]   Analysis of PU.1/ICSBP (IRF-8) complex formation with various PU.1 mutants:: molecular cloning of rat lcsbp (Irf-8) cDNA [J].
Nakano, N ;
Nishiyama, C ;
Masuoka, N ;
Nishiyama, M ;
Yamane, H ;
Okumura, K ;
Ogawa, H .
IMMUNOGENETICS, 2005, 56 (12) :871-877
[32]   Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections [J].
Nakano, Nobuhiro ;
Nishiyama, Chiharu ;
Kanada, Shunsuke ;
Niwa, Yusuke ;
Shimokawa, Naomi ;
Ushio, Hiroko ;
Nishiyama, Makoto ;
Okumura, Ko ;
Ogawa, Hideoki .
BLOOD, 2007, 109 (11) :4846-4855
[33]   Functional analysis of PU.1 domains in monocyte-specific gene regulation [J].
Nishiyama, C ;
Nishiyama, M ;
Ito, T ;
Masaki, S ;
Masuoka, N ;
Yamane, H ;
Kitamura, T ;
Ogawa, H ;
Okumura, K .
FEBS LETTERS, 2004, 561 (1-3) :63-68
[34]   Overproduction of PU.1 in mast cell progenitors: its effect on monocyte- and mast cell-specific gene expression [J].
Nishiyama, C ;
Nishiyama, M ;
Ito, T ;
Masaki, S ;
Maeda, K ;
Masuoka, N ;
Yamane, H ;
Kitamura, T ;
Ogawa, H ;
Okumura, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (03) :516-521
[35]   Regulation of human FcεRI α-chain gene expression by multiple transcription factors [J].
Nishiyama, C ;
Hasegawa, M ;
Nishiyama, M ;
Takahashi, K ;
Akizawa, Y ;
Yokota, T ;
Okumura, K ;
Ogawa, H ;
Ra, C .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4546-4552
[36]   STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells [J].
Nosaka, T ;
Kawashima, T ;
Misawa, K ;
Ikuta, K ;
Mui, ALF ;
Kitamura, T .
EMBO JOURNAL, 1999, 18 (17) :4754-4765
[37]   The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity [J].
Nuriya, S ;
Yagita, H ;
Okumura, K ;
Azuma, M .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (06) :917-926
[38]   Cutting edge: A crucial role for B7-CD28 in transmitting T help from APC to CTL [J].
Prilliman, KR ;
Lemmens, EE ;
Palioungas, G ;
Wolfe, TG ;
Allison, JP ;
Sharpe, AH ;
Schoenberger, SP .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4094-4097
[39]   Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells [J].
Ritprajak, Patcharee ;
Hashiguchi, Masaaki ;
Azuma, Miyuki .
MOLECULAR THERAPY, 2008, 16 (07) :1323-1330
[40]   Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation [J].
Salomon, B ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :225-252